Filing Details
- Accession Number:
- 0001140361-11-012592
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-28 14:46:33
- Reporting Period:
- 2011-02-25
- Filing Date:
- 2011-02-28
- Accepted Time:
- 2011-02-28 14:46:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1184151 | R Conan Deady | One Idexx Drive Westbrook ME 04092 | Corp Vp, General Counsel & Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-02-25 | 23,054 | $17.14 | 42,401 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-02-25 | 18,072 | $25.45 | 60,473 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-02-25 | 9,472 | $38.34 | 69,945 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-02-25 | 43,484 | $77.05 | 26,461 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-02-25 | 7,114 | $75.85 | 19,347 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-02-25 | 23,054 | $0.00 | 23,054 | $17.14 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-02-25 | 18,072 | $0.00 | 18,072 | $25.45 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-02-25 | 9,472 | $0.00 | 9,472 | $38.34 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-02-06 | No | 4 | M | Direct | |
| 0 | 2014-02-04 | No | 4 | M | Direct | |
| 0 | 2013-02-13 | No | 4 | M | Direct |
Footnotes
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $77.33 to $76.57, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $76.31 to $75.80, inclusive.
- Grant of options to buy shares of common stock becomes exercisable as to 6,400 shares on 02/06/2004, 02/06/2005, 02/06/2006, 02/06/2007, and the remaining 564 shares on 02/06/2008.
- Grant of options to buy shares of common stock becomes exercisable as to 4,400 shares on 02/05/2005, 02/05/2006, 02/05/2007, 02/05/2008, and the remaining 472 shares on 02/05/2009.
- Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (02/14/2007) of the date of grant.
Billionaire Hedge Funds
